Aclaris Therapeutics, Inc. Contracts & Agreements

101 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Securities Purchase Agreement, dated November 18, 2024, by and between the Company and the investors named therein
Purchase Agreements
Aclaris Therapeutics, Inc.
2024
Form of Registration Rights Agreement, dated November 18, 2024, by and between the Company and the investors named therein
Registration Rights Agreements
Aclaris Therapeutics, Inc.
2024
Employment Agreement, dated as of November 18, 2024, by and between the Company and Hugh Davis
Employment Agreements
Aclaris Therapeutics, Inc.
2024
Aclaris Therapeutics, Inc. 2024 Inducement Plan
Aclaris Therapeutics, Inc.
2024
Form of Stock Option Grant Notice and Stock Option Agreement used in connection with the Aclaris Therapeutics, Inc. 2024 Inducement Plan
Stock Agreements
Aclaris Therapeutics, Inc.
2024
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement used in connection with the Aclaris Therapeutics, Inc. 2024 Inducement Plan
Stock Agreements
Aclaris Therapeutics, Inc.
2024
Royalty Purchase Agreement, effective as of July 16, 2024, by and between the Registrant and OCM IP Healthcare Portfolio LP
Purchase Agreements
Aclaris Therapeutics, Inc.
2024
Description of Securities
Aclaris Therapeutics, Inc.
2024
Second Amended and Restated Employment Agreement, effective as of February 1, 2024, by and between the Registrant and Joseph Monahan
Employment Agreements
Aclaris Therapeutics, Inc.
2024
Separation Agreement, Waiver, and Release, dated as of February 4, 2024, by and between the Registrant and Douglas Manion
Separation Agreements
Aclaris Therapeutics, Inc.
2024
Letter Agreement, dated as of January 31, 2024, by and between the Registrant and Neal Walker
Aclaris Therapeutics, Inc.
2024
Amended and Restated Employment Agreement, effective as of July 1, 2023, by and between the Company and Joseph Monahan
Employment Agreements
Aclaris Therapeutics, Inc.
2023
(a Delaware limited liability company) (a Delaware corporation) Rentable Square Feet First Floor Suite 103 Chesterbrook Corporate Center 701 Lee Road Wayne, Pennsylvania
Aclaris Therapeutics, Inc.
2023
Ninth Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Aclaris Therapeutics, Inc.
2023
Amendment No. 1 to Consulting Services Agreement, dated as of March 23, 2023, by and between the Company and Frank Ruffo
Consulting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2023
Eighth Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Aclaris Therapeutics, Inc.
2023
Letter Agreement, dated as of November 22, 2022, by and between the Registrant and Neal Walker
Aclaris Therapeutics, Inc.
Pharmaceuticals
2023
Separation Agreement and General Release, dated as of December 9, 2022, by and between the Registrant and Frank Ruffo
Separation Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2023
Consulting Agreement, dated as of January 1, 2023, by and between the Registrant and Frank Ruffo
Consulting Agreements
Aclaris Therapeutics, Inc.
2023
Amended and Restated Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Douglas Manion
Employment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2023
Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Kevin Balthaser
Employment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2023
Sales Agreement, dated February 23, 2023, by and among Aclaris Therapeutics, Inc., SVB Securities LLC and Cantor Fitzgerald & Co
Sales Agreements
Aclaris Therapeutics, Inc.
2023
Employment Agreement, dated as of June 27, 2022, by and between the Registrant and Gail Cawkwell
Employment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2022
Employment Agreement, dated as of August 1, 2022, by and between the Company and Douglas Manion
Employment Agreements
Aclaris Therapeutics, Inc.
2022
Sixth Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2022
Employment Agreement, dated as of January 12, 2022, by and between the Registrant and Joseph Monahan
Employment Agreements
Aclaris Therapeutics, Inc.
2022
Employment Agreement, dated as of January 31, 2022, by and between the Registrant and James Loerop
Employment Agreements
Aclaris Therapeutics, Inc.
2022
Severance Agreement and General Release, dated as of November 1, 2021, by and between the Registrant and Kamil Ali-Jackson
Severance Agreements
Aclaris Therapeutics, Inc.
2022
Severance Agreement and General Release, dated as of January 7, 2022, by and between the Registrant and David Gordon
Severance Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2022
Seventh Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2022
Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Company and Neal Walker
Employment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2022
Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Company and Frank Ruffo
Employment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2022
Fifth Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2021
Underwriting Agreement by and among Aclaris Therapeutics, Inc., Jefferies LLC, SVB Leerink LLC and Piper Sandler & Co., dated June 9, 2021
Underwriting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2021
Sales Agreement, dated May 20, 2021, by and among Aclaris Therapeutics, Inc., SVB Leerink LLC and Cantor Fitzgerald & Co
Sales Agreements
Aclaris Therapeutics, Inc.
2021
Description of Securities
Aclaris Therapeutics, Inc.
2021
Fourth Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Aclaris Therapeutics, Inc.
2021
Change in Control Severance Benefit Plan, effective January 1, 2017, as amended by First Amendment to Change in Control Severance Benefit Plan, effective October 2, 2019
Change of Control Agreements
Aclaris Therapeutics, Inc.
2021
Underwriting Agreement by and among Aclaris Therapeutics, Inc., Cantor Fitzgerald & Co. and William Blair & Company, L.L.C., dated January 20, 2021
Underwriting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2021
Purchase Agreement, dated as of August 13, 2020, by and between the Company and Lincoln Park
Purchase Agreements
Aclaris Therapeutics, Inc.
2020
Registration Rights Agreement, dated as of August 13, 2020, by and between the Company and Lincoln Park
Registration Rights Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2020
First Amendment to Clinical and Commercial Supply Agreement, dated as of June 12, 2020, by and between the Registrant and PeroxyChem LLC
Supply Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2020
Second Amendment to Sublease, dated as of April 29, 2020, by and between the Registrant and Auxilium Pharmaceuticals, LLC
Lease Agreements
Aclaris Therapeutics, Inc.
2020
Loan and Security Agreement, by and among the Company, Confluence Discovery Technologies, Inc. and Silicon Valley Bank, dated as of March 30, 2020
Loan Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2020
Warrant to Purchase Stock, issued to Silicon Valley Bank, dated as of March 30, 2020
Warrant Agreements
Aclaris Therapeutics, Inc.
2020
Open Market Sale Agreement, dated March 13, 2020, by and between Aclaris Therapeutics, Inc. and Jefferies LLC
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2020
Description of Securities
Aclaris Therapeutics, Inc.
Pharmaceuticals
2020
Second Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Aclaris Therapeutics, Inc.
2020
Third Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Aclaris Therapeutics, Inc.
2020
Employment Agreement with Frank Ruffo, dated as of September 17, 2015
Employment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2020
First Amendment to License and Collaboration Agreement, by and between the Company and Rigel Pharmaceuticals, Inc. dated as of October 15, 2019
Collaboration Agreements
Aclaris Therapeutics, Inc.
2019
Asset Purchase Agreement, by and between the Company and EPI Health, LLC, dated as of October 10, 2019
Purchase Agreements
Aclaris Therapeutics, Inc.
2019
Form of Performance Stock Option Grant Notice and Stock Option Agreement used in connection with the 2015 Equity Incentive Plan
Bonus & Incentive Agreements
Aclaris Therapeutics, Inc.
2019
Form of Performance Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement used in connection with the 2015 Equity Incentive Plan
Bonus & Incentive Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
DE
2019
Amended & Restated Non-Employee Director Compensation Policy
Compensation Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2019
First Amendment to Sublease, dated as of December 13, 2017, by and between the Registrant and Auxilium Pharmaceuticals, LLC
Lease Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2019
Loan and Security Agreement, dated as of October 15, 2018, by and among Oxford Finance LLC, the lenders party thereto, the Registrant, Confluence Discovery Technologies, Inc. and...
Loan Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2019
Asset Purchase Agreement, by and between the Company and Allergan Sales, LLC, dated as of October 15, 2018, as amended on November 30, 2018
Purchase Agreements
Aclaris Therapeutics, Inc.
2018
Exclusive Patent License Agreement, by and between the Company and Allergan, Inc., dated as of November 30, 2018
License Agreements
Aclaris Therapeutics, Inc.
2018
Underwriting Agreement by and among Aclaris Therapeutics, Inc., Leerink Partners LLC and Evercore Group L.L.C., dated October 17, 2018
Underwriting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2018
Distribution Agreement, by and between the Registrant and McKesson Specialty Care Distribution Corporation, dated as of October 13, 2017, as amended by Amendment No. 1, dated as...
Distribution Agreements
Aclaris Therapeutics, Inc.
2018
First Amendment to License Agreement, by and between The Trustees of Columbia University in the City of New York and the Registrant, dated as of June 27, 2018
License Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2018
Commercial Supply Manufacturing Services Agreement, by and between the Registrant and James Alexander Corporation, dated as of January 24, 2018
Supply Agreements
Aclaris Therapeutics, Inc.
2018
3,260,000 Aclaris Therapeutics, Inc. Common Shares UNDERWRITING AGREEMENT
Underwriting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2017
Seventh Amendment to Services Agreement between the Registrant and NST Consulting, LLC, dated as of May 11, 2017
Consulting Agreements
Aclaris Therapeutics, Inc.
2017
Aclaris Therapeutics, Inc. 2017 Inducement Plan Adopted by the Board of Directors: July 31, 2017
Aclaris Therapeutics, Inc.
2017
Aclaris Therapeutics, Inc. 2017 Inducement Plan Stock Option Grant Notice
Stock Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2017
Aclaris Therapeutics, Inc. Restricted Stock Unit Grant Notice (2017 Inducement Plan)
Stock Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
DE
2017
Employment Agreement with Kamil Ali-Jackson, dated as of September 17, 2015
Employment Agreements
Aclaris Therapeutics, Inc.
2017
FOURTH AMENDMENT TO AMENDED AND RESTATED SUBLEASE BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC.
Lease Agreements
Aclaris Therapeutics, Inc.
2017
SIXTH AMENDMENT TO SERVICES AGREEMENT BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC.
Consulting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2017
4,000,000 Aclaris Therapeutics, Inc. Common Shares UNDERWRITING AGREEMENT
Underwriting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2016
ACLARIS THERAPEUTICS, INC. $75,000,000 COMMON STOCK SALES AGREEMENT
Stock Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2016
AMENDMENT TO ASSIGNMENT AGREEMENT
Assignment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2016
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Aclaris Therapeutics, Inc.
2016
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2016
STOCK PURCHASE AGREEMENT
Stock Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
DE
2016
EXCLUSIVE LICENSE AGREEMENT
License Agreements
Aclaris Therapeutics, Inc.
2016
THIRD AMENDMENT TO SERVICES AGREEMENT BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC.
Consulting Agreements
Aclaris Therapeutics, Inc.
2016
FOURTH AMENDMENT TO SERVICES AGREEMENT BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC.
Consulting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2016
FIFTH AMENDMENT TO SERVICES AGREEMENT BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC.
Consulting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2016
THIRD AMENDMENT TO AMENDED AND RESTATED SUBLEASE BETWEEN NST CONSULTING, LLC AND ACLARIS THERAPEUTICS, INC.
Lease Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2016
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
Aclaris Therapeutics, Inc.
2015
EMPLOYMENT AGREEMENT
Employment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2015
EMPLOYMENT AGREEMENT
Employment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2015
LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
DE
2015
ACLARIS THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE
Bonus & Incentive Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2015
ACLARIS THERAPEUTICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2015 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
DE
2015
ACLARIS THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Compensation Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
2015
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
Aclaris Therapeutics, Inc.
2015
EMPLOYMENT AGREEMENT
Employment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2015
[ ] Aclaris Therapeutics, Inc. Common Shares UNDERWRITING AGREEMENT
Underwriting Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
NY
2015
ASSIGNMENT AGREEMENT
Assignment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
CA
2015
ACLARIS THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: SEPTEMBER 15, 2015 APPROVED BY THE STOCKHOLDERS: SEPTEMBER 16, 2015 EFFECTIVE DATE: [],...
Bonus & Incentive Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
DE
2015
ACLARIS THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
Aclaris Therapeutics, Inc.
2015
ACLARIS THERAPEUTICS, INC. AMENDED AND RESTATED 2012 EQUITY COMPENSATION PLAN
Compensation Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
DE
2015
LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Aclaris Therapeutics, Inc.
2015
CLINICAL AND COMMERCIAL SUPPLY AGREEMENT
Supply Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2015
SERVICES AGREEMENT
Services Agreements
Aclaris Therapeutics, Inc.
2015
ASSIGNMENT AGREEMENT
Assignment Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
CA
2015
FINDERS SERVICES AGREEMENT
Services Agreements
Aclaris Therapeutics, Inc.
2015